hydroxychloroquine has been researched along with thromboplastin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khamashta, M; Mehdi, AA; Uthman, I | 1 |
| Khamashta, M; Merashli, M; Noureldine, MH; Uthman, I | 1 |
| Aguirre, MA; Barbarroja, N; Cuadrado, MJ; Jimenez-Gomez, Y; Lopez-Pedrera, Ch; Pérez-Sánchez, C; Ruiz-Limon, P | 1 |
| Canisius, A; Lackner, KJ; Manukyan, D; Müller-Calleja, N; Strand, D | 1 |
| Breen, K; Hunt, BJ; Parmar, K; Rand, JH; Schreiber, K; Wu, XX | 1 |
| Boone, BA; Doerfler, WR; Ellis, JT; Liang, X; Lotze, MT; Miller-Ocuin, J; Murthy, P; Neal, MD; Ross, MA; Sperry, JL; Wallace, CT; Zeh, HJ | 1 |
| Benhamou, Y; Billoir, P; Damian, L; Galas, L; Joannides, R; Jouen, F; Le Besnerais, M; Le Cam-Duchez, V; Levesque, H; Miranda, S; Richard, V; Schapman, D; Thiebaut, PA | 1 |
3 review(s) available for hydroxychloroquine and thromboplastin
| Article | Year |
|---|---|
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.
Topics: Annexin A2; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiphospholipid Syndrome; Complement Activation; Humans; Hydroxychloroquine; Immunologic Factors; Monocytes; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Rituximab; Thromboplastin | 2010 |
Antiphospholipid syndrome: an update.
Topics: Adrenal Cortex Hormones; Animals; Annexin A2; Anticoagulants; Antiphospholipid Syndrome; Drugs, Investigational; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Immunosuppressive Agents; MAP Kinase Signaling System; Mice; Phosphatidylinositol 3-Kinases; Plasmapheresis; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Assessment; Rituximab; Secondary Prevention; Thromboplastin; Thrombosis; TOR Serine-Threonine Kinases | 2015 |
Immunotherapy in antiphospholipid syndrome.
Topics: Animals; Anticoagulants; Antiphospholipid Syndrome; Biological Products; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunotherapy; Rituximab; Thromboplastin; Ubiquinone | 2015 |
4 other study(ies) available for hydroxychloroquine and thromboplastin
| Article | Year |
|---|---|
Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase.
Topics: Adult; Aged; Animals; Antibodies, Antiphospholipid; Antirheumatic Agents; Cells, Cultured; Disease Models, Animal; Endosomes; Enzyme Induction; Female; Gene Expression; Humans; Hydroxychloroquine; Immunoglobulin G; Interleukin-1beta; Intravital Microscopy; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Middle Aged; Monocytes; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Protein Transport; Reactive Oxygen Species; Signal Transduction; Thromboplastin; Tumor Necrosis Factor-alpha; Vena Cava, Inferior; Venous Thrombosis; Young Adult | 2017 |
The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies.
Topics: Adolescent; Adult; Aged; Annexin A5; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Antirheumatic Agents; beta 2-Glycoprotein I; C-Reactive Protein; Complement C3a; Complement System Proteins; Hemostasis; Humans; Hydroxychloroquine; Immunoglobulin G; Middle Aged; Neovascularization, Physiologic; Prospective Studies; Thrombelastography; Thromboplastin; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult | 2018 |
Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps.
Topics: Adenocarcinoma; Animals; Chloroquine; DNA; Extracellular Traps; Female; Humans; Hydrolases; Hydroxychloroquine; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Platelet Aggregation; Protein-Arginine Deiminase Type 4; Receptor for Advanced Glycation End Products; Thrombelastography; Thrombophilia; Thromboplastin; Venous Thromboembolism | 2018 |
Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hydroxychloroquine; Male; Mice; Nitric Oxide Synthase Type III; Thrombin; Thromboplastin; Thrombosis; Vascular Cell Adhesion Molecule-1 | 2019 |